DD207716A5 - Verfahren zur herstellung von 1,2,4-triazinen und von pyrazinen - Google Patents
Verfahren zur herstellung von 1,2,4-triazinen und von pyrazinen Download PDFInfo
- Publication number
- DD207716A5 DD207716A5 DD83248497A DD24849783A DD207716A5 DD 207716 A5 DD207716 A5 DD 207716A5 DD 83248497 A DD83248497 A DD 83248497A DD 24849783 A DD24849783 A DD 24849783A DD 207716 A5 DD207716 A5 DD 207716A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- bis
- formula
- methylphenyl
- preparation
- triazin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/16—Halogen atoms; Nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/18—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Luminescent Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Inks, Pencil-Leads, Or Crayons (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/354,982 US4513135A (en) | 1982-03-05 | 1982-03-05 | Diaryl-pyrazine derivatives affecting GABA binding |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD207716A5 true DD207716A5 (de) | 1984-03-14 |
Family
ID=23395746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD83248497A DD207716A5 (de) | 1982-03-05 | 1983-03-04 | Verfahren zur herstellung von 1,2,4-triazinen und von pyrazinen |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US4513135A (fi) |
| EP (1) | EP0088593B1 (fi) |
| JP (1) | JPS58162582A (fi) |
| KR (1) | KR860000847B1 (fi) |
| AT (1) | ATE27457T1 (fi) |
| AU (1) | AU547581B2 (fi) |
| CA (1) | CA1195327A (fi) |
| DD (1) | DD207716A5 (fi) |
| DE (1) | DE3371786D1 (fi) |
| DK (1) | DK97283A (fi) |
| ES (2) | ES520340A0 (fi) |
| FI (1) | FI830708L (fi) |
| GB (1) | GB2116179B (fi) |
| GR (1) | GR78459B (fi) |
| HU (1) | HU191368B (fi) |
| IL (1) | IL68002A (fi) |
| NZ (1) | NZ203428A (fi) |
| PH (1) | PH22535A (fi) |
| PL (1) | PL240871A1 (fi) |
| PT (1) | PT76312B (fi) |
| RO (1) | RO86320B (fi) |
| ZA (1) | ZA831387B (fi) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2567518B1 (fr) * | 1984-07-11 | 1987-11-13 | Sanofi Sa | Nouveaux composes a noyau heterocyclique azote, leur preparation et les medicaments qui en contiennent |
| JPH06501926A (ja) * | 1990-08-06 | 1994-03-03 | 藤沢薬品工業株式会社 | 複素環式化合物 |
| GB9420010D0 (en) * | 1994-10-01 | 1994-11-16 | Marck Sharp & Dohme Limited | Nucleic acids |
| BR9710536A (pt) | 1996-07-24 | 1999-08-17 | Warner Lambert Co | Isobutilgaba e seus derivados para o tratamento da dor |
| TWI316055B (fi) * | 2001-04-26 | 2009-10-21 | Nippon Shinyaku Co Ltd | |
| KR100490893B1 (ko) * | 2002-10-11 | 2005-05-23 | (주) 비엔씨바이오팜 | 2-메톡시-1,3,5-트리아진 유도체, 그 제조방법 및 이를 포함하는 항바이러스용 약학적 조성물 |
| US20070003394A1 (en) * | 2005-02-01 | 2007-01-04 | Carey Paul G | Anti-cross threading fastener |
| AR053712A1 (es) * | 2005-04-18 | 2007-05-16 | Neurogen Corp | Heteroarilos sustituidos, antagonistas de cb1 (receptor 1 canabinoide) |
| EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
| US7678363B2 (en) | 2005-08-26 | 2010-03-16 | Braincells Inc | Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs |
| EP1940389A2 (en) | 2005-10-21 | 2008-07-09 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
| US20070112017A1 (en) * | 2005-10-31 | 2007-05-17 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| MX2008014320A (es) | 2006-05-09 | 2009-03-25 | Braincells Inc | Neurogenesis mediada por el receptor de 5-hidroxitriptamina. |
| AU2007249399A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| EP2531492B1 (en) | 2010-02-05 | 2016-04-13 | Heptares Therapeutics Limited | 1,2,4-triazine-4-amine derivatives |
| GB201106829D0 (en) | 2011-04-21 | 2011-06-01 | Proximagen Ltd | Heterocyclic compounds |
| TW201321353A (zh) * | 2011-10-08 | 2013-06-01 | Novartis Ag | 胺基甲酸酯／尿素衍生物 |
| JP6916279B2 (ja) * | 2016-07-12 | 2021-08-11 | レヴォリューション・メディスンズ，インコーポレイテッド | アロステリックｓｈｐ２阻害剤としての２，５−二置換３−メチルピラジンおよび２，５，６−三置換３−メチルピラジン |
| WO2018101312A1 (ja) * | 2016-11-30 | 2018-06-07 | 田辺三菱製薬株式会社 | トリアジン化合物の製造方法 |
| EP4230623A3 (en) | 2017-01-23 | 2023-10-11 | Revolution Medicines, Inc. | Pyridine compounds as allosteric shp2 inhibitors |
| WO2018136265A1 (en) | 2017-01-23 | 2018-07-26 | Revolution Medicines, Inc. | Bicyclic compounds as allosteric shp2 inhibitors |
| EP3678703A1 (en) | 2017-09-07 | 2020-07-15 | Revolution Medicines, Inc. | Shp2 inhibitor compositions and methods for treating cancer |
| CA3078565A1 (en) | 2017-10-12 | 2019-04-18 | Revolution Medicines, Inc. | Pyridine, pyrazine, and triazine compounds as allosteric shp2 inhibitors |
| EP3724189B1 (en) | 2017-12-15 | 2023-10-04 | Revolution Medicines, Inc. | Polycyclic compounds as allosteric shp2 inhibitors |
| LT3788049T (lt) | 2018-05-01 | 2023-07-25 | Revolution Medicines, Inc. | Rapamicino analogai, sujungti su c40-, c28- ir c32-, kaip mtor inhibitoriai |
| IL312291A (en) | 2018-05-01 | 2024-06-01 | Revolution Medicines Inc | C-26-linked rapamycin analogs as MTOR inhibitors |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3172889A (en) * | 1965-03-09 | Process for the separation of z-methyl- | ||
| US3294638A (en) * | 1961-06-05 | 1966-12-27 | Warner Lambert Pharmaceutical | Method and compositions employing 2-alkyl-3-piperidinopyrazines |
| CH480795A (de) * | 1967-03-01 | 1969-11-15 | Sandoz Ag | Mittel zur Beeinflussung des Pflanzenwachstums |
| US3948894A (en) * | 1974-01-31 | 1976-04-06 | Eli Lilly And Company | 3-Amino-5,6-diaryl-1,2,4-triazines |
| US3979516A (en) * | 1974-01-31 | 1976-09-07 | Eli Lilly And Company | Anti-inflammatory 3-amino-5,6-diaryl-1,2,4-triazines |
| US4013654A (en) * | 1974-01-31 | 1977-03-22 | Eli Lilly And Company | 5,6-diaryl-1,2,4-triazines |
| US3989831A (en) * | 1974-01-31 | 1976-11-02 | Eli Lilly And Company | Topically-active anti-inflammatory 3-chloro-5,6-diaryl-1,2,4-triazines |
| US4081542A (en) * | 1975-04-21 | 1978-03-28 | Merck & Co., Inc. | Piperazinylpyrazines |
| GB1493998A (en) * | 1975-06-03 | 1977-12-07 | Beecham Group Ltd | Propanolamine derivatives |
| US4008232A (en) * | 1975-06-23 | 1977-02-15 | Eli Lilly And Company | 3-Amino-5,6-diaryl-1,2,4-triazines |
| US4082844A (en) * | 1976-02-09 | 1978-04-04 | Merck & Co., Inc. | 6-chloro-2-(1-piperazinyl)pyrazine |
| US4021553A (en) * | 1976-03-10 | 1977-05-03 | Eli Lilly And Company | 5,6-Diaryl-1,2,4-triazines as topically-active anti-inflammatory agents |
| US4018923A (en) * | 1976-03-10 | 1977-04-19 | Eli Lilly And Company | 5,6-Diaryl-1,2,4-triazines as topically-active anti-inflammatory agents |
| US4190725A (en) * | 1976-03-10 | 1980-02-26 | Eli Lilly And Company | 5,6-Diaryl-1,2,4-triazines |
| DE2810052A1 (de) * | 1977-03-09 | 1978-09-14 | Fabre Sa Pierre | Aminoaryl-1,2,4-triazine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel |
| US4157392A (en) * | 1977-05-17 | 1979-06-05 | Diamond Shamrock Corporation | Pharmacologically active substituted 1,2,4-triazines |
| US4251527A (en) * | 1977-05-17 | 1981-02-17 | Diamond Shamrock Corporation | Pharmacologically active substituted 1,2,4-triazines |
| GB1604084A (en) * | 1977-05-17 | 1981-12-02 | Diamond Shamrock Corp | Pharmaceutical preparations containing 1,2,4-triazine derivatives |
-
1982
- 1982-03-05 US US06/354,982 patent/US4513135A/en not_active Expired - Fee Related
-
1983
- 1983-02-28 RO RO110181A patent/RO86320B/ro unknown
- 1983-02-28 DK DK97283A patent/DK97283A/da not_active Application Discontinuation
- 1983-02-28 IL IL68002A patent/IL68002A/xx unknown
- 1983-03-01 NZ NZ203428A patent/NZ203428A/en unknown
- 1983-03-01 PH PH28587A patent/PH22535A/en unknown
- 1983-03-01 ZA ZA831387A patent/ZA831387B/xx unknown
- 1983-03-01 PT PT76312A patent/PT76312B/pt unknown
- 1983-03-02 JP JP58035221A patent/JPS58162582A/ja active Pending
- 1983-03-02 FI FI830708A patent/FI830708L/fi not_active Application Discontinuation
- 1983-03-02 KR KR1019830000833A patent/KR860000847B1/ko active
- 1983-03-03 CA CA000422805A patent/CA1195327A/en not_active Expired
- 1983-03-03 GB GB08305846A patent/GB2116179B/en not_active Expired
- 1983-03-03 DE DE8383301142T patent/DE3371786D1/de not_active Expired
- 1983-03-03 AT AT83301142T patent/ATE27457T1/de not_active IP Right Cessation
- 1983-03-03 EP EP83301142A patent/EP0088593B1/en not_active Expired
- 1983-03-03 AU AU12029/83A patent/AU547581B2/en not_active Ceased
- 1983-03-04 GR GR70688A patent/GR78459B/el unknown
- 1983-03-04 ES ES520340A patent/ES520340A0/es active Granted
- 1983-03-04 DD DD83248497A patent/DD207716A5/de unknown
- 1983-03-04 HU HU83762A patent/HU191368B/hu unknown
- 1983-03-04 PL PL24087183A patent/PL240871A1/xx unknown
- 1983-10-06 ES ES526297A patent/ES8504173A1/es not_active Expired
-
1985
- 1985-01-04 US US06/688,946 patent/US4585861A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| HU191368B (en) | 1987-02-27 |
| CA1195327A (en) | 1985-10-15 |
| NZ203428A (en) | 1986-09-10 |
| ZA831387B (en) | 1984-10-31 |
| IL68002A (en) | 1986-09-30 |
| ATE27457T1 (de) | 1987-06-15 |
| EP0088593A3 (en) | 1984-05-23 |
| US4513135A (en) | 1985-04-23 |
| RO86320B (ro) | 1985-03-31 |
| GB8305846D0 (en) | 1983-04-07 |
| KR840004101A (ko) | 1984-10-06 |
| KR860000847B1 (ko) | 1986-07-09 |
| GB2116179A (en) | 1983-09-21 |
| FI830708A0 (fi) | 1983-03-02 |
| ES526297A0 (es) | 1985-04-16 |
| DK97283D0 (da) | 1983-02-28 |
| GR78459B (fi) | 1984-09-27 |
| DK97283A (da) | 1983-09-06 |
| AU1202983A (en) | 1983-09-08 |
| PH22535A (en) | 1988-10-17 |
| FI830708L (fi) | 1983-09-06 |
| GB2116179B (en) | 1985-09-11 |
| DE3371786D1 (en) | 1987-07-02 |
| EP0088593A2 (en) | 1983-09-14 |
| IL68002A0 (en) | 1983-06-15 |
| ES8504173A1 (es) | 1985-04-16 |
| PL240871A1 (en) | 1984-06-18 |
| PT76312A (en) | 1983-04-01 |
| EP0088593B1 (en) | 1987-05-27 |
| US4585861A (en) | 1986-04-29 |
| PT76312B (en) | 1986-02-04 |
| ES8404346A1 (es) | 1984-04-16 |
| JPS58162582A (ja) | 1983-09-27 |
| ES520340A0 (es) | 1984-04-16 |
| RO86320A (ro) | 1985-03-15 |
| AU547581B2 (en) | 1985-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DD207716A5 (de) | Verfahren zur herstellung von 1,2,4-triazinen und von pyrazinen | |
| DE69804273T2 (de) | 5h-Thiazolo[3,2-a]pyrimidinderivate | |
| DE69317436T2 (de) | 1,4-benzothiazepine verwendbar als neurologische mittel | |
| EP0031080B1 (de) | 2-Acylaminomethyl-1,4-benzodiazepine und deren Salze sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE2940483A1 (de) | 5h-2,3-benzodiazepinderivate, verfahren zur herstellung derselben und diese enthaltende arzneimittel | |
| DD211555A5 (de) | Verfahren zur herstellung neuer 4-amino-6,7-dimethoxychinolin-derivate | |
| DE2237765A1 (de) | Neue aminoderivate von pyrazolo (3,4-b)pyridin-5-carbonsaeuren mit deren estern und salzen, verfahren zu ihrer herstellung und ihre verwendung | |
| DE69420738T2 (de) | Bicyclische heterocyclen als neurokinin a antagonisten | |
| CH634308A5 (de) | Verfahren zur herstellung neuer pyrimidonderivate. | |
| DE1907670B2 (de) | Basisch substituierte Dibenzo [b.f.] oxepine bzw. -thiepine und deren pharmazeutisch verträgliche Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Mittel | |
| DE2321705A1 (de) | Benzodiazepinderivate, ihre herstellung und verwendung | |
| DE60027429T2 (de) | Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien | |
| DE60111568T2 (de) | Tetrahydro-(benzo- oder thieno-)azepin-pyrazin und triazinderivative als mglur 1 antagonisten | |
| DE19629378A1 (de) | Neue Triazolopurine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
| DE602004012268T2 (de) | Imidazol-Derivate und ihre Verwendung in der Behandlung von mGluR5-Rezeptor vermittelten Krankheiten | |
| DE10061541A1 (de) | Arylamino-Dihydropyrimidinone | |
| EP0054839B1 (de) | 2-Acylaminomethyl-1,4-benzodiazepine und deren Salze sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE3404193C2 (fi) | ||
| DE2943286C2 (fi) | ||
| EP0212551B1 (de) | Neue Tetraoxoverbindungen | |
| EP0180833B1 (de) | 4-Oxo-pyrido[2,3]pyrimidin-Derivate, Verfahren zur deren Herstellung und diese ethaltende Arzneimittel | |
| DE2221808C2 (de) | Hydrazinopyridazin-Derivate, deren Säureadditionssalze, Verfahren zu deren Herstellung und Heilmittel | |
| EP0177907A1 (de) | Neue 2-Pyridin-thiol-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate | |
| DE2849107A1 (de) | 2,6-diphenyl-3,7-dioxabicyclo 3.3.0 octan-4,8-dion-derivate verfahren zu ihrer herstellung und sie enthaltende mittel | |
| DE2435041C3 (de) | 8-Substituierte 6-Aryl-4H-s-triazolo [3,4c] thieno [23e] 1,4-diazepine, Verfahren zu ihrer Herstellung, ihre Verwendung in Arzneimitteln und diese enthaltende pharmazeutische Präparate |